TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmacosweden AB
Closing information (x1000 NOK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
17,386
|
17,127
|
14,518 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
824
|
817
|
666 |
| EBITDA |
1,533
|
1,403
|
1,078 |
| Total assets |
8,672
|
8,452
|
7,036 |
| Current assets |
5,426
|
6,811
|
5,914 |
| Current liabilities |
3,257
|
3,362
|
2,844 |
| Equity capital |
5,414
|
5,090
|
4,192 |
| - share capital |
101
|
104
|
95 |
| Employees (average) |
9
|
9
|
9 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
62.4%
|
60.2%
|
59.6% |
| Turnover per employee |
1,932
|
1,903
|
1,613 |
| Profit as a percentage of turnover |
4.7%
|
4.8%
|
4.6% |
| Return on assets (ROA) |
9.5%
|
9.7%
|
9.5% |
| Current ratio |
166.6%
|
202.6%
|
207.9% |
| Return on equity (ROE) |
15.2%
|
16.1%
|
15.9% |
| Change turnover |
778
|
1,344
|
4,299 |
| Change turnover % |
5%
|
9%
|
42% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
29% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.